MedPath

APO-LISDEXAMFETAMINE CHEWABLE TABLETS

APO-LISDEXAMFETAMINE CHEWABLE TABLETS

Approved
DIN Number

02534460

Drug Class

Human

Market Date

May 23, 2025

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02534460
AIG Number0152536001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA I)
A
ATC Code
N06BA12 LISDEXAMFETAMINE
Product Specifications
Dosage FormTablet (Chewable)
Route of AdministrationOral
AHFS Classification28:20.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

LISDEXAMFETAMINE DIMESYLATEActive
Strength: 30 MG
Monograph: LISDEXAMFETAMINE DIMESYLATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.